Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JPT Peptide Technologies is a Berlin-based peptide specialist that develops and manufactures custom and catalog peptide products for life science research, translational research, and clinical support applications. The company focuses on custom peptide synthesis, peptide pools, peptide libraries, peptide arrays, bioconjugates, and quantified reference peptides used in immunology, immunotherapy, proteomics, enzyme profiling, vaccine research, and cell therapy workflows. JPT positions itself as a service and technology partner rather than a therapeutic drug developer, offering both products and contract research services. Its proprietary product families include PepMix for antigen-specific T-cell stimulation, PepStar peptide microarrays, PepTrack peptide libraries, and SpikeTides reference peptides for biomarker quantification. The company operates production and laboratory activities in Berlin and markets itself as ISO 9001:2015 certified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JPT Peptide Technologies.